Anxiety and depression tied to retinal nerve fiber layer decline in glaucoma: Study
CAPTION
Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the eye.
CREDIT
Rob Felt, Georgia Tech
According to a recent research report, patients with anxiety showed faster rates of retinal nerve fiber layer (RNFL) decline, as measured by OCT.
Glaucoma is optic neuropathy characterized by progressive loss of retinal ganglion cells. There is currently no effective treatment for ganglion cell degeneration, and the treatment of glaucoma is focused on preventing progression. Therefore, glaucoma is considered a chronic disease that requires lifelong management.
With this background, researchers investigated the association of anxiety and depression with glaucoma progression, and elucidate mechanisms underlying that. They included 251 eyes with open angle glaucoma who were followed up for at least 2 years in this retrospective case–control study. The Beck Anxiety Inventory (BAI) and Beck Depressive Inventory-II (BDI-II) were used to assess anxiety and depression in glaucoma patients. Patients were classified into groups (high-anxiety group; HA-G, low-anxiety group; LA-G, high-depression group; HD-G, low-depression group; LD-G) according to their score on the BAI or BDI-II (separately).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.